Statement attributable to:
Robert McLean, MD, FACP
President, Ñî¹óåú´«Ã½
Washington, DC (May 15, 2019) —The Ñî¹óåú´«Ã½ (ACP) is deeply concerned that policies introduced by state legislatures in recent weeks, including Alabama and Georgia, will significantly infringe on the patient-physician relationship and patient autonomy. ACP firmly rejects any legislation that creates barriers to care and threatens access to health care services for women and their families.
Washington, D.C. May 15, 2019 -- The Ñî¹óåú´«Ã½ (ACP) awarded Vivek Murthy, MD the Joseph F. Boyle Award for Distinguished Public Service today at ACP’s annual advocacy day, Leadership Day, a two-day event where ACP member internists and medical students learn about the legislative process and key policy issues from ACP staff, members of Congress, congressional staff, and independent policy analysts.
Statement attributable to:
Robert McLean, MD, FACP
President, Ñî¹óåú´«Ã½
Washington, DC (May 9, 2019) —The Ñî¹óåú´«Ã½ (ACP) is encouraged by the final rule announced by the Trump Administration to require pharmaceutical manufacturers to disclose the cost of drugs in television advertisements. ACP believes that this is a promising step in improving transparency in prescription drug pricing. Prescription medications are only as effective as a patient’s ability to access and adhere to treatment as prescribed.
Statement attributable to:
Robert McLean, MD, FACP
President, Ñî¹óåú´«Ã½
Washington, DC (May 2, 2019) —Ñî¹óåú´«Ã½ (ACP) is encouraged by the passage of the Climate Action Now Act in the U.S. House of Representatives, which directs the U.S. to uphold its commitment to the Paris Agreement on Climate Change. ACP is deeply concerned about the negative impact that climate change is having on public health and patients, and that these effects will worsen without immediate action.
